$496 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -416,000 | -100.0% | -0.03% | – |
| TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -0.37% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -109,000 | -100.0% | -0.45% | – |
| DVA | Exit | DAVITA INC | $0 | – | -33,000 | -100.0% | -0.52% | – |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.52% | – |
| PRVA | Exit | PRIVIA HEALTH GROUP INC | $0 | – | -130,000 | -100.0% | -0.62% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -109,000 | -100.0% | -0.91% | – |
| DOCS | Exit | DOXIMITY INCcl a | $0 | – | -131,000 | -100.0% | -0.92% | – |
| WBA | Exit | WALGREENS BOOTS ALLIANCE INC | $0 | – | -125,000 | -100.0% | -0.98% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -150,000 | -100.0% | -1.10% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -100,000 | -100.0% | -1.72% | – |
| ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -65,000 | -100.0% | -1.74% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -140,000 | -100.0% | -1.99% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -200,000 | -100.0% | -2.03% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -120,000 | -100.0% | -2.16% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -44,000 | -100.0% | -2.45% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -100,000 | -100.0% | -2.96% | – |
| Exit | MADRIGAL PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -3.05% | – | |
| CI | Exit | CIGNA CORP NEW | $0 | – | -45,000 | -100.0% | -3.13% | – |
| DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -100,000 | -100.0% | -3.28% | – |
| Exit | CYTOKINETICS INCcall | $0 | – | -400,000 | -100.0% | -3.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.